Treatment Exposure and Discontinuation in the PALbociclib CoLlaborative Adjuvant Study of Palbociclib with Adjuvant Endocrine Therapy for Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer (PALLAS/AFT-05/ABCSG-42/BIG-14-03)

Erica L. Mayer, Christian Fesl, Dominik Hlauschek, Laura Garcia-Estevez, Harold J. Burstein, Nicholas Zdenkowski, Viktor Wette, Kathy D. Miller, Marija Balic, Ingrid A. Mayer, David Cameron, Eric P. Winer, José Juan Ponce Lorenzo, Diana Lake, Gunda Pristauz-Telsnigg, Tufia C. Haddad, Lois Shepherd, Hiroji Iwata, Matthew Goetz, Fatima CardosoTiffany A. Traina, Dhanusha Sabanathan, Urs Breitenstein, Kerstin Ackerl, Otto Metzger Filho, Karin Zehetner, Kadine Solomon, Sarra El-Abed, Kathy Puyana Theall, Dongrui Ray Lu, Amylou Dueck, Michael Gnant, Angela DeMichele

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Treatment Exposure and Discontinuation in the PALbociclib CoLlaborative Adjuvant Study of Palbociclib with Adjuvant Endocrine Therapy for Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer (PALLAS/AFT-05/ABCSG-42/BIG-14-03)'. Together they form a unique fingerprint.

Medicine & Life Sciences